Novel CCL21-Vault Nanocapsule Intratumoral Delivery Inhibits Lung Cancer Growth

BACKGROUND: Based on our preclinical findings, we are assessing the efficacy of intratumoral injection of dendritic cells (DC) transduced with an adenoviral vector expressing the secondary lymphoid chemokine (CCL21) gene (Ad-CCL21-DC) in a phase I trial in advanced non-small cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kar, Upendra K., Srivastava, Minu K., Andersson, Åsa, Baratelli, Felicita, Huang, Min, Kickhoefer, Valerie A., Dubinett, Steven M., Rome, Leonard H., Sharma, Sherven
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086906/
https://www.ncbi.nlm.nih.gov/pubmed/21559281
http://dx.doi.org/10.1371/journal.pone.0018758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086906/
https://www.ncbi.nlm.nih.gov/pubmed/21559281
http://dx.doi.org/10.1371/journal.pone.0018758

Ejemplares similares